Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA) -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (1186)	6/7/1999 11:22:00 AM
From: bob zagorin	Read Replies (1) \| Respond to of 1870

Genta Moves to New Corporate Headquarters LEXINGTON, Mass., June 7 /PRNewswire/ -- Genta Incorporated (Nasdaq: GNTA), a developer of antisense-based cancer therapy, announced today that it has moved its worldwide corporate headquarters to accommodate the Company's focus on the antisense-based cancer therapy development, and to better manage its resource efficiency. Effective immediately, Genta's new headquarters is 99 Hayden Avenue, Suite 200 Lexington, MA 02421 Tel: 781-860-5150, Fax: 781-860-5137 E-mail address: info@genta.com "The move to our new headquarters is further evidence of our commitment to reduce expenses while focusing on the development of our G3139 Anticode(TM) oligonucleotide technology," said Kenneth G. Kasses, Ph.D., President and CEO of Genta. "In April, we closed our operations in San Diego, CA and moved to Lexington, Mass., which will allow us to more effectively and efficiently manage our clinical trials." Genta Incorporated is a biopharmaceutical company whose strategy consists of building a product and technology portfolio concentrating on its Anticode(TM) (antisense) products intended to treat cancer at its genetic source. To receive Genta Incorporated's latest news release and other corporate announcements via fax, at no cost, dial 1-800-PRO-INFO; use the Company's symbol GNTA. Or visit The Financial Relations Board's web site at www.frbinc.com. SOURCE Genta Incorporated CO: Genta Incorporated ST: Massachusetts IN: MTC SU: 06/07/99 10:16 EDT prnewswire.com